Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pirfenidone in Advanced Liver Fibrosis
NCT04099407Phase 2Completed
- Sponsor
- Grupo Mexicano para el Estudio de las Enfermedades Hepáticas
- Start
- Aug 2019
- Primary completion
- Aug 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of pirfenidone in Liver Fibrosis (LF), sponsored by Grupo Mexicano para el Estudio de las Enfermedades Hepáticas. Started Aug 2019; status: completed.
02
Drugs
pirfenidone
03
Conditions
Liver Fibrosis (LF)
Beyond the preview
Go deeper on NCT04099407.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04099407.